Frequency of Chlamydia pneumonia & Mycoplasma pneumonia in patients admitted with exacerbation of COPD by قبادی مراللو, حسن et al.


























ϭ΍̵ΎϬΘϨϣ̶Αζϧ΍ΩϦϴ̩ ϪηϮΧ ΎΗ ΩΎϬϧΖϨϣϦϣ ήΑϪ̯ ΍έ̵΍ΪΧαΎ̢γ
ϡϮη. ϦδΣήΘ̯Ω̵Ύϗ΁ΏΎϨΟ ϡ΍ ϪϳΎϤϧ΍ή̳ ΩΎΘγ΍ ί΍ήΘ̯Ω̵Ύϗ΁ΏΎϨΟ ϭ̵ΩΎΒϗ
ί΍ ϭ ˭ϥΎηΪϨϤηίέ΍̵Ύϫ ΖϳΎϤΣ ϭ Ύϫ ̶ϳΎϤϨϫ΍έ ϞϴϟΩ ϪΑ ϩΩ΍ίΐϴΒΣ ϡ΍ήϬη
ϝΎϤ̯ϥΎθϐϳέΩ̶Α̵ΎϫΕέϮθϣϞϴϟΩϪΑ̵ΪϤΤϣ̶ϠϋϦϴδΣήΘ̯Ω̵Ύϗ΁ΏΎϨΟ
ϡέ΍Ω ΍έ̶ϧ΍ΩέΪϗϭ ή̰θΗ.ϪϧΎϤγϢϧΎΧιϮμΧϪΑ ˬϩΩ΍ϮϧΎΧ̵Ύπϋ΍ϡΎϤΗ ί΍
ή̡Ϧϳ΍ϡΎΠϧ΍ΕΪϣϡΎϤΗέΩϪ̯̵ή̴δϋ̶ΟΎΣέ΍ΩέϮΧήΑϥΎθϳΎϫΖϳΎϤΣί΍ϩ̫ϭ









































































COPD: Chronic Obstructive Pulmonary Disease
AECOPD: Acute Exacerbation Chronic Obstructive Pulmonary Disease
GOLD: Global Initiative for Obstructive Lung Disease





RSV: Respiratory Syncytial Virus
HRQoL: Health-Related Quality of Life
FVC: Forced Vital Capacity
RV: Residual Volume
TLC: Total Lung Capacity





COPD ˬϠϣΎϋ ΪϨ̩ϲγέήΑ ΖΤΗ ίϮϨϫ ϭ Ζγ΍ϲΖγ΍.̫Ϯϟϭήγ ΕΎόϟΎτϣϳ̡ ϝΎ̰ϴϪ ̯ ΪϧΩή̯ ΩΎϬϨθ
ΎϣϳΎϤγϼ̡Ϯ̰ϧϮϣϮϨ̡ϴϣϼ ̯ϭϪϴΪϳϧϮϣϮϨ̡ΎϴθϘϧΖγ΍Ϧ̰ϤϣϪϲΩΎΣϪϠϤΣέΩ΍έCOPD΍ϳΪϨϨ̯Ύϔ.
ΎϫεϭέϭΩ΍Ϯϣ:˻˹˹ϣήγϪϧϮϤϧϲί΍˺˹˹ΑϴϪΑϼΘΒϣέΎϤAECOPDγϭϪΑϴϪϠϱΪΘϣELISAέΩ
γέήΑΖϬΟϲΎϣ ϪΑϝ΍έϮϣϮϫΦγΎ̡ϳϣϼ ̯ϭΎϤγϼ̡Ϯ̰ϴΪϳϧϮϣϮϨ̡ΎϴΖϓή̳έ΍ήϗ ϪόϟΎτϣΩέϮϣϪ.˺˹˹
ϝϼΧέΩ ϪϧϮϤϧήΘδΑϱΧ΍ϴ΍ήΑήϱ̳ ϩί΍Ϊϧ΍ϴήϱIgMϭ ΪηϪΘϓή̳̊ ΪόΑϪΘϔϫ˺˹˹ϩέΎΑϭΩ ϪϧϮϤϧ
΍ήΑϱίέ΍ϳΑΎϲIgGΪηϪΘϓή̳.
ϳΎϫϪΘϓΎ:Ϟ ̯ί΍˺˹˹ΑϴέΎϤ̀˼)̃̀˼(ϭ˭Ωήϣ˻̀)̃˻̀(΍έΩϥίϳΪϧΩϮΑ ϪόϟΎτϣϦ.ϣϴ̴ϧΎϴϨγϦϲ
Αϴϥ΍έΎϤ̋/́±˼̀/̀̊ΩϮΑ.ηϴΎϣΖϧϮϔϋωϮϳϧϮϣϮϨ̡ ΎϤγϼ̡Ϯ̰ϴϣϼ̯ϭ ϪϴΪϳϧϮϣϮϨ̡Ύϴ̃ Ϫ˺˼̃ϭ˺̊
Ζγ΍.̃έΩϥΎϣΰϤϫΖϧϮϔῢΑϴΩϮΑΩϮϬθϣϥ΍έΎϤ.ϣςγϮΘϣϴϥ΍ΰFEV1ˬ˺˺˺˹̀˻̂±̊̌̌˼˼
 έΩϭ ΩϮΑStage 2̊˹ ˬΩέϮϣStage 3̋̋ϭ ΩέϮϣStage 4̋ΪϧΩϮΑ ΩέϮϣ.ηϴΎϣωϮϳΎϤγϼ̡Ϯ̰
ϧϮϣϮϨ̡ϴϪγέΩϪStageΗήΗϪΑϒϠΘΨϣϴ̃ΐ̋-̃̊/˺̌̃ϭ̊˹΍ήΑϩϭϼϋΩϮΑϳέΩϦStageΎϫϱή̯Ϋ
ηϩΪηϴϣϼ ̯ΖϧϮϔϋωϮϴΪϳϧϮϣϮϨ̡Ύϴ̃Ϫ̋/˺˻̃ˬ˺̊̃ϭ˻˹ΩϮΑΩϮϬθϣ.
Θϧϴ̳ ϪΠϴήϱ:ϳ̡ Ύϫ ϪΘϓΎϴ ϩΪϨϨ ̯ ΩΎϬϨθϱ΍ϳΎϫΖϧϮϔϋ Ϫ ̯ Ζγ΍ϦϱΗ΁ϴ̢ϴϣήψϧ ϪΑ̮ϲΚϋΎΑ Ϊγέ
΍ΰϓ΍ϳΪθΗ ζϳ ϪϠϤΣ ΪCOPDϣϲΪϧΩή̳.΍ ήΑ ϩϭϼϋϳΑ Ϧγ Ϧϴέ΍Ω ΎϨόϣ ρΎΒΗέ΍ ϥ΍έΎϤϱΖϧϮϔϋ ΎΑ























Ζγ΍ϦϣΰϣΖϴθϧϭήΑϭ ϡΰϴϔϣ΁ ϲϨϴϟΎΑ Ϟ̰η ϭΩ ϞϣΎηϭ ΩϮη.ϳέϥ΁ ϩΪϤϋϱΎϫέϮΘ̯Ύϓ̮δϞϣΎη
έΎ̴ϴγϱΎϫΖϧϮϔϋˬϭϲϠϐηϱΎϫαΎϤΗˬϲδϔϨΗ...Ζγ΍)˼(.ϩΪϨϨ ̯ΪϳΪθΗϭϩΪϨϨ̯ϊϳήδΗϞϣ΍Ϯϋί΍
ΕϼϤΣCOPDΎϳήΘ Ύ̯ΑϱΎϫΖϧϮϔϋϱϧϮϔϋϭ Ύϫ ϩέϭΩί΍ϱέΎϴδΑέΩϡϮγ̮ϳέΩϲδϔϨΗϱΎϫΖ
Ζγ΍Ωέ΍Ϯϣ)̊(.ΕϼϤΣΪϳΪθΗCOPDθηϮ ̯βϔϧϲ̴ϨΗΕέϮλϪΑϲΕέΪϗέΩήΘθϴΑΖϳΩϭΪΤϣϭ
έΎϤϴΑέΩϲϠϐηήϴϏϭϲϠϐηϱΎϫΖϴϟΎόϓϡΎΠϧ΍ϢΠΣζϳ΍ΰϓ΍ˬΪηΎΑϲϣϲ̯ή̩ςϠΧέϮϬχΎϳϭςϠΧ.











Ζγ΍ϱϮϳέϱΎϫϝϮ΋Ϯϟ΁(ϦϣΰϣΖϴθϧϭήΑϭ)ϩ΍ήϤϫϦϣΰϣϱέΎϤϴΑ Ϫ ̯ Ωέ΍ΩϲϨϴϟΎΑϒϳήόΗ Ϫ̯
έΩϭςϠΧϭϪϓήγΪηΎΑϲϣϦϣΰϣϪϓήγΎΑΩέ΍ϮϣήϳΎγ(ΩΩή ̯ϲϣϢϴδϘΗ)˻(.
˼xϪϴϧϮϣϮϨ̡ΎϳΪϴϣϼ̯:
΍Ζγ΍ ϲϟϮϠγ ϞΧ΍Ω ϱέΎΒΟ΍ Ϟ̴ϧ.΍ΪΘΑ΍ ϡΎδΟ΍ϱΖγ΍ Ϣ̯΍ήΘϣ ϥϭήΘ̰ϟ΍ Ϊϴ΋ϮϠ̯Ϯϧ ϱ΍έ΍Ω Ϫ ̯ Ωέ΍Ω.
΍ΪΘΑ΍ϢδΟϱΎθϏϱΎϫϦϴΌΗϭή̡ϱΖγ΍ϱΩΪόΘϣϲοήϋϱΎϫΪϧϮϴ̡ϱ΍έ΍Ω.ϭΩή ̳ϱΎϫϥϮϳίϮϠ̰ϧ΍ΪϴϟϮΗ
ϥ΁ί΍̮ϳ̫ϮϟϭήγωϮϧ̮ϳςϘϓϭΖγ΍ ϡϭΎϘϣΎϫΪϴϣΎϧϮϔϟϮγϪΑΖΒδϧϭΪϨ̯ϲϣϥ̫Ϯ̰ϴϠ̳ϭ Ϣ ΍̯ήΘϣ
ΎϨηΎγϳ̶Ζγ΍ϩΪη.
xϪϴϧϮϣϮϨ̡ΎϤγϼ̡Ϯ̰ϳΎϣ:
ϱΎϬτϴΤϣέΩϭ ΪϨηΎΑϪΘη΍ΩΩ΍ί΁ϲ̳ΪϧίΪϨϧ΍ϮΘϴϣ Ϫ ̯ ΪϨΘδϫΖόϴΒσέΩ ΩϮΟϮϣ ϢδϴϧΎ̳έ΍ϦϳήΘ̰̩Ϯ̯
ΪϨΑΎϳήϴΜ̰ΗϲϫΎ̴θϳΎϣί΁Ζθ̯.ΎΟϪΑϭΖγ΍ϲϟϮϠγΖΨγϩέ΍ϮϳΩΪϗΎϓ΍ήϳίΖγ΍ωϮϨΘϣϥ΁ϝΎ̰η΍ϱ






















ϡϮγϪϴοήϓ:Ϩγϩϭή̳ϲΑϴΎϣΖϧϮϔϋίϭήΑΎΑϥ΍έΎϤϳγϼ̡Ϯ̰ϧϮϣϮϨ̡ ΎϤϴϣϼ̯ϭ ϪϴΪϳϧϮϣϮϨ̡ ΎϴρΎΒΗέ΍ Ϫ
Ωέ΍Ω
Key points
̋COPD is very common & its incidence is rising globally
COPD is often associated with & worsens outcome of a variety of other
cigarette-related disease such as heart disease & lung cancer.
COPD is a complex disease caused by an environmental insult , most
often cigarette smoke , on a susceptible genetic background.
COPD is characterized by airflow obstruction that is not fully
reversible. Airflow obstruction may be secondary to narrowing of
small airways or emphysema.
Airway narrowing is a result of excess mucus production , airway
fibrosis , inflammation , and hypertrophy of structural cells.
Oxygen therapy is indicated for patients with resting hypoxemia (Sao2
 87%) and / or sings of pulmonary hypertension.
Beta-Agonists , anticholinergics , and inhaled corticosteroids have all
been shown to improve function , reduce symptoms , and reduce
exacerbations.
Pulmonary rehabilitation is an important and underutilized treatment
in patients with moderate to advanced COPD.
Lung volume reduction surgery and transplantation offer significant
benefits for highly selected patients with advanced COPD.
AECOPD is the course of COPD is characterized by episodic periods of
worsening symptoms.
